Covid-19, SARS, MERS

Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV), part of the Coronaviridae family, is a singlestranded RNA enveloped virus 100-140nm in diameter. SARS-CoV is associated with severe pneumonia, acute respiratory distress and has a high risk of a fatal outcome (10% morality rate). SARS-CoV was first identified in 2003 when an epidemic commenced in China, where it was thought to be spread from small mammals (most likely bats) to humans. SARS can be spread by inhaling small droplets of nasal secretions, via direct contact with an infected person.

Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Like SARS-CoV, MERS-CoV is part of the Coronaviridae family, but seems to have originated in Saudi Arabia in 2012. It is believed to have originated in bats, with camels suggested as a possible intermediate host. MERS-CoV causes similar symptoms to SARS-CoV including acute respiratory distress, but has a higher mortality rate (around 30%). The route of transmission is thought to be similar to SARS-CoV, primarily via respiratory droplets, but transmission via the oral route or via urine cannot yet be excluded.

98%(2h)*

* Both influenza and coronavirus are enveloped viruses, and our antiviral technology is based on radical physical and chemical principles, although we cannot perform coronavirus laboratory tests due to the danger level of the SARS/MERS, according to the similar chemical structure of those viruses, The effect of our technology on coronavirus should be similar to that of influenza A.